Cited by 123Neuroscience and Neuropharmacology ResearchNeurotransmitter Receptor Influence on BehaviorSubstance Abuse Treatment and Outcomes

Metabotropic glutamate receptor 5 (mGluR5) regulation of ethanol sedation, dependence and consumption: Relationship to acamprosate actions

Open access
Blednov, Yuri A., Adron Harris, R.·2008·The International Journal of Neuropsychopharmacology

Abstract

Recent studies have demonstrated that metabotropic glutamate receptor 5 (mGluR5) antagonists decrease alcohol self-administration and suggest that the anti-craving medication, acamprosate, may also act to decrease mGluR5 function. To address the role of mGluR5 in behavioural actions of ethanol and acamprosate, we compared mutant mice with deletion of the mGluR5 gene and mice treated with a mGluR5 antagonist (MPEP) or acamprosate. Lack of mGluR5 or administration of MPEP reduced the severity of alcohol-induced withdrawal (AW), increased the sedative effect of alcohol (duration of loss of righting reflex; LORR), and increased basal motor activity. The motor stimulation produced by ethanol was blocked by deletion of mGluR5, but not by injection of MPEP. Both acamprosate and MPEP increased ethanol-induced LORR and reduced AW. Importantly, the protective effects of both MPEP and acamprosate on AW were found when the drugs were injected before, but not after, injection of ethanol. This indicates that the drugs prevented development of dependence rather than merely producing an anticonvulsant action. No effects of acamprosate or MPEP on ethanol-induced LORR and AW were found in mGluR5 knockout mice, demonstrating that mGluR5 is required for these actions. mGluR5 null mutant mice showed decreased alcohol consumption in some, but not all, tests. These data show the importance of mGluR5 for several actions of alcohol and support the hypothesis that some effects of acamprosate require mGluR5 signalling.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1017/s1461145708008584

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Acamprosate acts as an NMDA receptor antagonist and modulates mGluR5 receptors.

    “Acamprosate acts as an NMDA receptor antagonist and modulates mGluR5 receptors [54].”

    From A Narrative Review of Current and Emerging Trends in the Treatment of Alcohol Use Disorder (2024) · cites this paper as [54]

    The Discussion says acamprosate may attenuate NMDA signalling and may inhibit mGluR5 function, supporting a possible role for both pathways. It does not establish that acamprosate acts as an NMDA receptor antagonist or directly modulates mGluR5; it notes that recombinant-receptor studies found no interaction with acamprosate. The discussion of possible direct NMDA blockade concerns MPEP, not acamprosate. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Blednov, Y. A., & Adron Harris, R.
Affiliations
The University of Texas at Austin (US)
Corresponding author
Blednov, Yuri A.
Venue
The International Journal of Neuropsychopharmacology
Published
2008-04-01
Volume
11
Issue
06
Pages
775-93
ISSN
  • 1461-1457 (ISSN-L)
  • 1469-5111
OpenAlex
W2099858791
Cited by
123
References
54
Citations by year
2025: 3 · 2024: 4 · 2023: 2 · 2022: 1 · 2021: 4 · 2020: 4 · 2019: 6 · 2018: 8 · 2017: 5 · 2016: 6 · 2015: 7 · 2014: 15 · 2013: 10 · 2012: 17
FWCI
4.47
Type
journal article
Language
en
Open access
Locations
  • The International Journal of Neuropsychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria
  • National Institutes of Health (5r01aa006399-36)
  • U.S. Public Health Service (A06399)
  • National Institute on Alcohol Abuse and Alcoholism (R01-AA006399, AA U01 13520, U01AA013520)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Keywords
metabotropic glutamate receptor 5, acamprosate, MPEP, ethanol sedation, alcoholism, alcohol self-administration, alcohol consumption, loss of righting reflex, motor stimulation
MeSH terms
Acamprosate, Alcohol Deterrents, Alcohol Drinking, Ethanol, Alcoholism, Analysis of Variance, Animals, Behavior, Animal, Central Nervous System Depressants, Choice Behavior, Conditioning, Operant, Dose-Response Relationship, Drug, Drug Interactions, Female, Male, Mice, Inbred C57BL, Motor Activity, Pyridines, Reflex, Self Administration, Sex Factors, Taurine, Receptors, Metabotropic Glutamate, Mice, Knockout, Excitatory Amino Acid Antagonists, Mice, Receptor, Metabotropic Glutamate 5

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review